These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diabetic dyslipidemia. Kreisberg RA Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665 [TBL] [Abstract][Full Text] [Related]
3. [Epidemiology of cardio-vascular complications of diabetes]. Grimaldi A; Heurtier A Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988 [TBL] [Abstract][Full Text] [Related]
4. Insulin resistance as a major determinant of increased coronary heart disease risk in postmenopausal women with Type 2 diabetes mellitus. Stoney RM; O'Dea K; Herbert KE; Dragicevic G; Giles GG; Cumpston GN; Best JD Diabet Med; 2001 Jun; 18(6):476-82. PubMed ID: 11472467 [TBL] [Abstract][Full Text] [Related]
5. Management of dyslipidemia in adults with diabetes. Haffner SM Diabetes Care; 1998 Jan; 21(1):160-78. PubMed ID: 9538988 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk factors and the prediabetic syndrome. Haffner SM Ann Med; 1996 Aug; 28(4):363-70. PubMed ID: 8862692 [TBL] [Abstract][Full Text] [Related]
10. The prediabetic problem: development of non-insulin-dependent diabetes mellitus and related abnormalities. Haffner SM J Diabetes Complications; 1997; 11(2):69-76. PubMed ID: 9101390 [TBL] [Abstract][Full Text] [Related]
11. Role of fibric acid derivatives in the management of risk factors for coronary heart disease. Després JP; Lemieux I; Robins SJ Drugs; 2004; 64(19):2177-98. PubMed ID: 15456334 [TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of blood glucose levels in the pathogenesis of (atherosclerotic) macroangiopathy]. Simon K Orv Hetil; 2004 Apr; 145(16):861-6. PubMed ID: 15156691 [TBL] [Abstract][Full Text] [Related]
14. The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome. Rett K Diabetes Obes Metab; 1999 May; 1 Suppl 1():S8-16. PubMed ID: 11220289 [TBL] [Abstract][Full Text] [Related]
15. Diabetic dyslipidaemia: insights for optimizing patient management. Vergès B Curr Med Res Opin; 2005; 21 Suppl 1():S29-40. PubMed ID: 15811197 [TBL] [Abstract][Full Text] [Related]
16. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Lamarche B; Lemieux I; Després JP Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189 [TBL] [Abstract][Full Text] [Related]
17. Type II diabetes mellitus. Edelman SV Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk continuum: implications of insulin resistance and diabetes. Hsueh WA; Law RE Am J Med; 1998 Jul; 105(1A):4S-14S. PubMed ID: 9707262 [TBL] [Abstract][Full Text] [Related]
19. Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease. Wannamethee SG; Lowe GD; Shaper AG; Rumley A; Lennon L; Whincup PH Diabetologia; 2004 Sep; 47(9):1557-65. PubMed ID: 15365613 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologic treatment of type 2 diabetic dyslipidemia. Moon YS; Kashyap ML Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]